Clinical trials recruiting for pMMR/MSS Adenocarcinoma of the Colon or Rectum
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| GV20-0251 | 2 |
| GV20-0251 and Pembrolizumab [KEYTRUDA®] | 1 |
| mFOLFOX6 | 1 |
| mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Indiana | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| New York | 1 |
| Oregon | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Study of GV20-0251 in Participants With Solid Tumor Malignancies
- mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Related conditions
Trials recruiting for pMMR/MSS Adenocarcinoma of the Colon or Rectum often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for pMMR/MSS Adenocarcinoma of the Colon or Rectum trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.